Google Cloud adds specialized AI models from SandboxAQ for scientific research

Google Cloud has announced the integration of specialized AI models from SandboxAQ into its cloud portfolio. Access to the technology will be available to corporate clients and research organizations — primarily in pharmaceuticals, materials science, and semiconductor manufacturing. The partnership expands Google Cloud's presence in niches where standard language models lack sufficient precision.

Models for Real Science

SandboxAQ spun out from Alphabet as an independent company in 2022. From the beginning, it chose a niche that major AI companies overlooked: problems requiring deep understanding of physics and chemistry—not just text processing about these subjects. SandboxAQ models are not universal language systems. They are trained on specialized scientific datasets: molecular structures, crystallographic parameters, spectral data, production metrics. Where GPT or Gemini 'know' about a molecule from textual descriptions, SandboxAQ models work directly with its structure.

Key areas available through Google Cloud:

• Drug discovery — identification of molecular candidates for new drugs, prediction of toxicity and interactions, early-stage screening of unpromising compounds
• Materials science — predicting properties of new materials, development of polymers and alloys with specified characteristics
• Semiconductor manufacturing — optimization of manufacturing processes, reduction of defects, improvement of chip yield
• Quantum security — development of cryptographic protocols resistant to quantum computer attacks

Why This Matters for Google Cloud

Google Cloud is methodically building an ecosystem of AI models beyond its own Gemini. Vertex AI already provides access to Anthropic Claude, Meta Llama, and other specialized providers. SandboxAQ fits into the strategy of a unified 'AI marketplace': corporate clients choose the tool suited to their task—all in one interface, without separate contracts.

For research organizations, this means concrete practical advantages. There is no need to build separate computational infrastructure, sign separate agreements, or configure integration with each provider individually. SandboxAQ models will be available through standard Google Cloud tools with familiar guarantees of data security and regulatory compliance—critical for pharmaceutical companies working with sensitive development projects. The connection with Alphabet is no accident: Alphabet remains one of SandboxAQ's key investors after its spinoff. Integration into Google Cloud is a logical continuation of these relationships, simultaneously strengthening the cloud division's position in segments with long-term corporate contracts.

What Changes for the Industry

Biotech startups and university labs traditionally face a difficult choice: build their own expensive computational infrastructure or accept the limited capabilities of general AI tools. The availability of specialized models through the cloud creates a third path—professional tools without capital investment in hardware.

In the semiconductor industry, AI optimization of manufacturing processes has already become a strategic priority. Increasing the yield of working chips by even a few percent at industrial scale means savings measured in hundreds of millions of dollars. Cloud access makes this tool practical not just for industry leaders, but for mid-scale manufacturers.

Drug development is another area with enormous potential. The traditional path from concept to market launch takes a decade and costs billions of dollars. AI acceleration of specific stages—compound screening, interaction prediction—can shorten this cycle and reduce research costs.

What This Means

Specialized scientific AI models are transitioning from research prototypes to commercial infrastructure. The arrival of SandboxAQ on Google Cloud lowers implementation barriers—technical and organizational simultaneously. For pharmaceuticals, materials science, and the semiconductor industry, where development cycles span years and the cost of mistakes is high, this represents a potential competitive advantage.

*Meta has been recognized as an extremist organization and is banned in the Russian Federation.